Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01093040 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Safety and Immunogenicity of the Drug CAT-354 in Healthy Japanese Subjects
A Phase 1 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01093040: Completed Phase 1 study, sponsored by MedImmune.
NCT01093040 is a Phase 1 study that has completed, run by MedImmune. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01093040, a Phase 1 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
To assess the safety of the administration of the drug (CAT-354) in healthy Japanese subjects.
Primary Outcome
The safety and tolerability of a single dose SC injection of CAT-354 in healthy male and/or female Japanese subjects will be assessed through the incidence of adverse events (AEs), and the assessment of vital signs, physical examinations, laboratory parameters, and electrocardiograms.
Interventions
- DRUG CAT-354
- DRUG CAT 354
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-04 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
What the finished NCT01093040 record still lists
NCT01093040 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which CAT-354 is the first listed.
NCT01093040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01093040 about?
NCT01093040 is a clinical study titled "A Study to Assess the Safety and Immunogenicity of the Drug CAT-354 in Healthy Japanese Subjects". To assess the safety of the administration of the drug (CAT-354) in healthy Japanese subjects.
What is the current status of trial NCT01093040?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2010-04. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01093040?
The interventions under investigation include: CAT-354 (DRUG), CAT 354 (DRUG).
Who is sponsoring clinical trial NCT01093040?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01093040's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia